<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Factor replacement products for bleeding or surgery in patients with rare inherited coagulation factor deficiencies</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Factor replacement products for bleeding or surgery in patients with rare inherited coagulation factor deficiencies</h1>
<div class="graphic"><div class="figure"><div class="ttl">Factor replacement products for bleeding or surgery in patients with rare inherited coagulation factor deficiencies</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="25%"></colgroup> <tbody> <tr> <td class="subtitle1">Deficient factor</td> <td class="subtitle1">Major bleeding/surgery (treat until healing is complete)</td> <td class="subtitle1">Minor bleeding/surgery (treat for 2 to 3 days)</td> <td class="subtitle1">Prophylaxis</td> </tr> <tr> <td> <p>XIII</p> Target level &gt;5%</td> <td> <p>rFXIII A-subunit: 35 international units/kg</p> <p>FXIII concentrate: 10 to 20 international units/kg</p> <p>FFP: 15 to 20 mL/kg</p> Cryoprecipitate: 1 unit/10 kg</td> <td> <p>rFXIII A-subunit: 35 international units/kg</p> <p>FXIII concentrate: 10 to 20 international units/kg</p> <p>FFP: 15 to 20 mL/kg</p> Cryoprecipitate: 1 unit/10 kg</td> <td> <p>rFXIII A-subunit: 35 international units/kg</p> <p>FXIII concentrate: 10 to 20 international units/kg</p> <p>FFP: 15 to 20 mL/kg</p> Cryoprecipitate: 1 unit/10 kg</td> </tr> <tr> <td> <p>X</p> Target level &gt;20%</td> <td> <p>FX concentrate: 25 international units/kg </p> <p>PCC (3 or 4 factor): 20 to 30 international units/kg</p> FFP: 15 to 20 mL/kg</td> <td> <p>FX concentrate: 25 international units/kg </p> <p>FFP: 15 to 20 mL/kg</p> </td> <td> <p>FX concentrate: 25 international units/kg</p> <p>PCC (3 or 4 factor)</p> FFP: 15 to 20 mL/kg</td> </tr> <tr> <td> <p>VII</p> Target level &gt;20%</td> <td> <p>rFVIIa: 15 to 30 mcg/kg</p> <p>FVII concentrate: 30 to 40 international units/kg</p> <p>PCC (4 factor): 20 to 30 international units/kg</p> FFP: 15 to 20 mL/kg</td> <td> <p>rFVIIa: 15 to 30 mcg/kg</p> <p>FVII concentrate: 30 to 40 international units/kg</p> FFP: 15 to 20 mL/kg</td> <td> <p>rFVIIa</p> FVII concentrate: 30 to 40 international units/kg</td> </tr> <tr> <td> <p>V</p> Target level &gt;20%</td> <td>FFP: 15 to 20 mL/kg</td> <td>FFP: 15 to 20 mL/kg</td> <td>FFP: 15 to 20 mL/kg</td> </tr> <tr> <td> <p>II</p> Target level &gt;30%</td> <td> <p>PCC (3 or 4 factor): 20 to 30 international units/kg</p> FFP: 15 to 20 mL/kg</td> <td>FFP: 15 to 20 mL/kg</td> <td>FFP: 15 to 20 mL/kg</td> </tr> </tbody></table></div><div class="graphic_lgnd">This table serves as a general guide but does not substitute for clinical judgment in the management of bleeding; early involvement of a hematologist or a hemophilia treatment center or a clinician with expertise in managing coagulation factor deficiencies is advised. Dose adjustments may be required depending on severity of bleeding and factor activity levels. PCCs generally are not used in cases of minor bleeding or minor surgery due to their potential prothrombotic risks. Refer to UpToDate topics on rare coagulation disorders for further details including dosing intervals, indications for prophylaxis, other potential therapies, potential risks and complications of therapy, and other aspects of management. Refer to UpToDate topics on hemophilia and factor XI deficiency for therapies used for factor VIII, IX, and XI deficiencies.</div><div class="graphic_footnotes">RICDs: rare inherited coagulation disorders; rFXIII A-subunit: recombinant factor XIII A-subunit; FFP: fresh frozen plasma; PCC: prothrombin complex concentrate; rFVIIa: recombinant activated factor VII.</div><div class="graphic_reference">Adapted from: Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004; 104:1243.</div><div id="graphicVersion">Graphic 98393 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
